Quality of life in patients with COPD and long term oxygen therapy
DOI:
https://doi.org/10.31053/1853.0605.v69.n2.21337Keywords:
COPD, LTOT, quality of life, SGRQ, anxiety, depressionAbstract
Chronic Obstructive Pulmonary Disease (COPD) leads to disability, being long-term oxygen therapy (LTOT) fundamental in final stages. It is important to assess its impact on patient's daily life.
Objectives: To describe factors that determine the quality of life in COPD patients with LTOT, taking into account demographic variables: age and sex, Physiological: POST BD FEV1, BMI, hours of use of OCD and SpO2,
Psychological: Dyspnea: St. George's questionnaire (SGRQ ) and Hospital Anxiety and depression Scale .
Material and Methods: Observational, cross. 26 patients were included without associated comorbidities.
Results: 73.07% male, age: 61.73 ± 1.48 years, the average hours of use of LTOT was equal to 18.88 ± 0.77 hours, the average post-BD FEV 1 was 34.23 ± 2.63%. More anxiety and depression were observed among females. Age had an inverse correlation with the lung function but it had positive lineal correlation with the perception of dyspnea. There was less perception of dyspnea with more hours of use of LTOT. Statistical significance was achieved for the perception of dyspnea and post BD FEV1 as well as with perception of dyspnea and anxiety /depression (p <0.05).
Conclusions: Anxiety and depression are highly prevalent symptoms in patients with severe COPD that also use LTOT, being higher in women. We stress the importance of using validated scales of quality of life and mental health status, to assess the overall impact of disease and optimize the treatment.
Downloads
References
Consiglio E, Belloso W H: Nuevos indicadores clínicos -La calidad de vida relacionada con la salud. Medicina (Buenos Aires) 2003; 63: 172-178
WHO. Constitution of the World Health Organization:Ten years of the World Health Organization (Annexe I). Geneva,1958.
Peces-Barba G, Barberá JA, Agustí A, Casanova C, Casas A, Izquierdo JL, Jardim J, López Varela V, Monsó E, Montemayor T , Viejo JL: Guía de práctica clínica de diagnóstico y tratamiento de la Enfermedad Pulmonar Obstructiva Crónica. Separ-Alat, 2009: 6-8
Rhodius E, Caneva J, Sivori M: Consenso argentino de oxigeno terapia crónica domiciliaria: Medicina (Buenos Aires) 1998; 58: 85-94
Report of the Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-5.
Nocturnal Oxygen Therapy Trial Group. 1980. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann. Intern. Med. 93: 391-398.
Weitzenblum E, Apprill M, Oswald M. Benefit from long-term O2 therapy in chronic obstructive pulmonary disease patients. Respiration. 1992; 59 Suppl 2:14-7.
Aibar Arregui MA, Laborda Ezquerra K, Conget López F: Relación entre datos objetivos y calidad de vida percibida por el paciente con EPOC. An. Med. Interna. Madrid, 2007; Vol. 24, N.º 10, 473-477
American Thoracic Society. 1995. ATS Statement: standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152: S77-S121.
GOLD: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. GOLDScience Committee. Oregon, Global initiative for chronic Obstructive Lung Disease; 2007:1-89
Aguilar Estrada MG, Sotelo Malagón M del C, Lara Rivas AG, García Flores A, Sansores Martínez RH, Ramírez Venegas A: Reproducibilidad del cuestionario respiratorio Saint George en la versión al español, en pacientes mexicanos con enfermedad pulmonar obstructiva crónica. Rev Inst Nal Enf Resp Mex Volumen 13 - número 2 Abril - junio 2000: 85-95
M. Ferrer, J. Alonso, L. Prieto, V. Plaza, E. Monsó, R. Marrades, M.C. Aguar, A. Khalaf, J.M. Antó: Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example . Eur Respir J, 1996, 9, 1160–1166.
Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, et al. Interpretation of quality of life scores from the St.
George’s respiratory questionnaire. Eur Respir J 2002; 19: 405-13.
R Philip Snaith: The Hospital Anxiety And Depression Scale; Health and Quality of Life Outcomes 2003, 1:29
Martin CR: What does the Hospital Anxiety and Depression Scale (HADS) Really Measure in Liaison Psychiatry Settings?; Current Psychiatry Reviews, 2005, 1, 69-73 69
De las Cuevas Castresana C, García Estrada Perez A, Gonzalez de Rivera JL: "Hospital Anxiety and Depression Scale" y Psicopatología Afectiva, Anales de psiquiatría, 1995, vol. 11. Nº 4: 126-130
Bentsen SB, Henriksen AH, Wentzel-Larsen T, Hanestad BR, Wahl AK: What determines subjective health status in patients with chronic obstructive pulmonary disease: importance of symptoms in subjective health status of COPD patients. Health Qual Life
Outcomes. 2008 Dec 18; 6:115.
Tsara V, Serasli E, Katsarou Z, Tsorova A, Christaki P: Quality of Life and Social-Economic Characteristics of Greek Male Patients on Long-Term Oxygen Therapy Respir Care 2008; 53(8):1048–1053.
Jones P W. Issues concerning HRQOL in COPD. Chest 1995; 107: 187 - 193.
Ketelaars CAJ, Schlösser MAG, Mostert R, Huyer H, Halfens RJG, Wouters EFM. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 39-43.
Ferrer M, Alonso J, Morera J, Marrades M, Khalaf A, Aguar C, et al. Chronic obstructive pulmonary disease stage and health related quality of life. Ann Intern Med 1997; 127: 1072-79.
Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating
the health related quality of life of patients with COPD. Chest 1999; 116: 1632 - 37.
Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005; 127(4):1205-1211
Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent
chronic obstructive pulmonary disease. J Cardiopulm Rehab 2001; 21(2):80-86
Maurer J, Rebbapragada V, Borson S, et al; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008; 134 (4 Suppl):43S-56S.
Van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002; 57(5):412-416.
Schols AMWJ,Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1791–1797.
Donahoe M, Rogers RM, Cottrell JJ. Is loss of body weight in chronic obstructive pulmonary disease patients with emphysema secondary to low tissue oxygenation? Respiration,1992;59 Suppl 2:33-9.
Laaban JP. Nutrition and bronchopneumopathie chronique obstructive. Rev Pneumol. Clin 1991; 47:235-250. 96
Laaban JP, Kouchakji B, Dore MF, et al. Nutritional status of patients with chronic obstructive pulmonary disease and acute respiratory failure. Chest 1993;103:1362–8.
Manterola C, Pineda V: El valor de “p” y la “significación estadística”. Aspectos generales y su valor en la práctica clínica. Interpretation of medical statistics. Revista Chilena de cirugía Febrero 2008 Vol 60 - Nº 1; págs. 86-89
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The generation of derivative works is allowed as long as it is not done for commercial purposes. The original work may not be used for commercial purposes.
How to Cite
